Clinical Research Details A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis Study Description The purpose of this study is to find out if OCA may be safe and effective in delaying specific medical conditions or health related issues that can occur in patients with NASH and evidence of liver fibrosis.Subjects will be randomized to 1 of 2 study drug doses or placebo. Open Enrollment Contact Name: Kelly JackmanContact Phone: (904) 633-0070Contact Email: Kelly.Jackman@jax.ufl.edu Investigators Principal Investigator Maged P. Ghali, M.D. Medicine Principal Investigator James S. Scolapio, M.D. Medicine